Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Capacity Expansion

Senores Pharmaceuticals Capacity Expansion: ₹43 Cr Investment

Senores Pharmaceuticals disclosed capacity expansion at three subsidiaries with total estimated cost of ₹43 Crore. Expansions adding ~1.5 Bn units/annum are expected by March 2027.

Key figures
Value₹43.00 Cr
Execution periodBy end of March 2027
manufacturing capacity addition (per annum)1502.7 Mn units
Source

NSE filing, NSE: SENORES. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Senores Pharmaceuticals Ltd: key numbers

Share price
₹1,294.80
Market cap
₹5,963 Cr
Revenue (annual)
₹632.6 Cr
Net profit (annual)
₹115.4 Cr
P/E (TTM)
47.2×Sector 46.1×
Promoter holding
45.82%+0.00% QoQ
FII holding
6.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Senores Pharmaceuticals Ltd

All →

Other capacity expansion announcements

All →